financial post
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
Financial Post • 5 DAYS AGO
Boehringer Ingelheim’s investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial
Financial Post • 5 DAYS AGO
Discovery Announces Details of Fourth Quarter and Full Year 2025 Results Conference Call and Webcast
Financial Post • 6 DAYS AGO
CANADA CARBON COMPLETES THIRD DRILLING CAMPAIGN ON ASBURY GRAPHITE PROPERTY
Financial Post • 6 DAYS AGO